All In Biotech

Drug Trial Radar · NCT01296191

Aqueous Absorption and Pharmacokinetics of Besivance Versus VIGAMOX in Patients Undergoing Phacoemulsification

Last checked: Nov 20, 2026Latest source record: Dec 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

120

Actual

Start

May 2011

Primary completion

Jan 2013

Study completion Jan 2013

Sponsor

Lead sponsor
Frank A. Bucci, Jr., M.D.Academic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 15, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Prevention
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare drug concentrations in aqueous humor following ocular instillation of Besivance and VIGAMOX in subjects undergoing cataract surgery.

Conditions

  • Cataracts

Interventions

  • MoxifloxacinDrug

    One drop 4 times daily for 3 days and one drop the day of sample collection

  • besifloxacinDrug

    One drop 4 times daily for 3 days and one drop on day of sample collection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetics in Aqueous Humor Samples.Time frame: Measured after 3 days of drug instillation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bucci Laser Vision Institute

    Wilkes-Barre, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.